Literature DB >> 28456807

Prevalence of Major Comorbidities in Chronic Obstructive Pulmonary Disease Caused by Biomass Smoke or Tobacco.

Rafael Golpe1, Irene Martín-Robles, Pilar Sanjuán-López, Esteban Cano-Jiménez, Olalla Castro-Añon, Noemí Mengual-Macenlle, Luis Pérez-de-Llano.   

Abstract

BACKGROUND: Comorbidities are very common in chronic obstructive pulmonary disease (COPD), contributing to the overall severity of the disease. The relative prevalence of comorbidities in COPD caused by biomass smoke (B-COPD), compared with COPD related to tobacco (T-COPD), is not well known.
OBJECTIVES: To establish if both types of COPD are associated with a different risk for several major comorbidities.
METHOD: The prevalence of comorbidities was compared in 863 subjects with B-COPD (n = 179, 20.7%) or T-COPD (n = 684, 79.2%). Multivariate analysis was carried out to explore the independent relationship between comorbidities and type of exposure.
RESULTS: Three comorbidities were more frequent in T-COPD than in B-COPD: ischemic heart disease (11.5 vs. 5.0%, respectively, p = 0.01), peripheral vascular disease (9.2 vs. 2.7%, p = 0.006), and peptic ulcer disease (4.8% vs. 0, p = 0.005). After correcting for potential confounding variables, the risk of ischemic heart disease was lower in B-COPD than in T-COPD (OR: 0.33, 95% CI: 0.16-0.69, p = 0.003).
CONCLUSIONS: The prevalence of ischemic heart disease is significantly lower in B-COPD than in T-COPD, suggesting a different systemic effect of both types of smoke in COPD patients.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Biomass; Cardiovascular risk factors; Chronic obstructive pulmonary disease; Comorbidity; Coronary artery disease; Tobacco

Mesh:

Substances:

Year:  2017        PMID: 28456807     DOI: 10.1159/000472718

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  5 in total

1.  Cardiovascular Studies in Patients with Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco.

Authors:  Rafael Golpe; Pilar Sanjuán-López; Irene Martín-Robles; Carlos González-Juanatey; Luis Pérez-de-Llano; José L López-Campos
Journal:  Lung       Date:  2018-02-12       Impact factor: 2.584

2.  In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity.

Authors:  Thibaud Soumagne; Alicia Guillien; Nicolas Roche; Isabella Annesi-Maesano; Pascal Andujar; Lucie Laurent; Stéphane Jouneau; Martial Botebol; Jean-Jacques Laplante; Jean-Charles Dalphin; Bruno Degano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-01

3.  Trends in morbidity and mortality from COPD in Brazil, 2000 to 2016.

Authors:  Liana Gonçalves-Macedo; Eliana Mattos Lacerda; Brivaldo Markman-Filho; Fernando Luiz Cavalcanti Lundgren; Carlos Feitosa Luna
Journal:  J Bras Pneumol       Date:  2019-11-25       Impact factor: 2.624

4.  Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.

Authors:  Rafael Golpe; Irene Martín-Robles; Pilar Sanjuán-López; Luis Pérez-de-Llano; Carlos González-Juanatey; José L López-Campos; Elena Arellano-Orden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-09-01

5.  The impact of exposure to biomass smoke versus cigarette smoke on inflammatory markers and pulmonary function parameters in patients with chronic respiratory failure.

Authors:  Birsen Ocakli; Eylem Acarturk; Emine Aksoy; Sinem Gungor; Fulya Ciyiltepe; Selahattin Oztas; Ipek Ozmen; Meltem Coban Agca; Cuneyt Salturk; Nalan Adiguzel; Zuhal Karakurt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.